Work

P1018 Optimizing Therapy in Challenging Crohn’s Disease: Higher Ustekinumab Levels Improve Biological Activity in a Refractory Cohort

Year: 2026

Type: conference-abstract

Source: Journal of Crohn s and Colitis

DOI: 10.1093/ecco-jcc/jjaf231.1199

Authors: J González Antuña, M Rodríguez Gallardo, T Valdes, M I Belvis Jiménez, M B Maldonado Pérez, M Romero González, V Merino Bóhórquez, M Á Calleja Hernández, F Argüelles Arias

Institution: Hospital Universitario Virgen Macarena

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7125190411

Cites:

Cited by:

Related to: